Skip to main content
Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
29.70
-0.74 (-2.43%)
At close: Dec 20, 2024, 4:00 PM
30.00
+0.30 (1.01%)
After-hours: Dec 20, 2024, 7:47 PM EST

Collegium Pharmaceutical Revenue

Collegium Pharmaceutical had revenue of $159.30M in the quarter ending September 30, 2024, with 16.53% growth. This brings the company's revenue in the last twelve months to $599.25M, up 9.62% year-over-year. In the year 2023, Collegium Pharmaceutical had annual revenue of $566.77M with 22.17% growth.

Revenue (ttm)
$599.25M
Revenue Growth
+9.62%
P/S Ratio
1.60
Revenue / Employee
$3,041,853
Employees
197
Market Cap
957.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023566.77M102.83M22.17%
Dec 31, 2022463.93M187.07M67.56%
Dec 31, 2021276.87M-33.15M-10.69%
Dec 31, 2020310.02M13.32M4.49%
Dec 31, 2019296.70M16.29M5.81%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Brookdale Senior Living 2.95B
HealthStream 287.99M
Avadel Pharmaceuticals 138.16M
Vir Biotechnology 78.62M
Zymeworks 62.20M
CeriBell 60.04M
Bicycle Therapeutics 36.90M
Revenue Rankings

COLL News

More News